You have 9 free searches left this month | for more free features.

metastatic gastric cancer,

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Gastric Cancer, PD-L1 Gene Amplification, FGFR2 Amplification Trial in New York (Nivolumab, Capecitabine,

Recruiting
  • Metastatic Gastric Cancer
  • +2 more
  • New York, New York
    Bureau for Cancer Research
May 10, 2023

Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab

Recruiting
  • Metastatic Gastric Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
  • Nivolumab Injection
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Aug 23, 2023

Gastric Cancer, Chemo Effect, Immune Checkpoint Inhibitor Trial in Shanghai (Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU)

Recruiting
  • Gastric Cancer
  • +2 more
  • Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 1, 2023

Metastatic Cancer, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer Trial (OB-002)

Not yet recruiting
  • Metastatic Cancer
  • +5 more
  • (no location specified)
Jul 10, 2023

Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)

Not yet recruiting
  • Gastric Cancer
  • Beijing, China
    Beijing Cancer Hospital
Aug 7, 2023

Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Amsterdam (89Zr-DFO*-trastuzumab PET scan)

Recruiting
  • Breast Cancer
  • +5 more
  • 89Zr-DFO*-trastuzumab PET scan
  • Amsterdam, Noord-Holland, Netherlands
    AmsterdamUMC
Jul 12, 2023

Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

Not yet recruiting
  • Metastatic Gastric Adenocarcinoma
  • +2 more
  • nal-IRI /Experimental
  • +2 more
  • (no location specified)
Jun 25, 2023

Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

Recruiting
  • Adenocarcinoma
  • +8 more
  • Radiotherapy targeted to the primary lesion
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 7, 2023

Metastatic Gastric Cancer, Surgery, Chemo Trial (Palliative surgery after translational therapy, Chemotheraoy along)

Not yet recruiting
  • Metastatic Gastric Cancer
  • +2 more
  • Palliative surgery after translational therapy
  • Chemotheraoy along
  • (no location specified)
Mar 30, 2022

HER2-positive Gastric Cancer, Immunotherapy Trial in Shanghai (Disitamab Vedotin combined with fruquintinib and Tislelizumab)

Recruiting
  • HER2-positive Gastric Cancer
  • Immunotherapy
  • Disitamab Vedotin combined with fruquintinib and Tislelizumab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 8, 2023

Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Rotterdam (Tusamitamab ravtansine)

Not yet recruiting
  • Metastatic Lung Cancer
  • +2 more
  • Tusamitamab ravtansine
  • Rotterdam, Netherlands
    Erasmus MC
Jan 26, 2023

Gastric Cancer Trial in Shanghai (Apatinib)

Completed
  • Gastric Cancer
  • Shanghai, Shanghai, China
    Shanghai 6th People's Hospital
Feb 24, 2022

HER2-positive Gastric Cancer Trial (HLX10, Trastuzumab and Chemotherapy)

Not yet recruiting
  • HER2-positive Gastric Cancer
  • HLX10, Trastuzumab and Chemotherapy
  • (no location specified)
Mar 28, 2022

Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Camrelizumab,

Not yet recruiting
  • Metastatic Gastric Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Guangzhou, Guangdong, China
    The Sixth Affiliated hosipital, Sun Yat-Sen University
Apr 16, 2022

Gastric Cancer Trial in Beijing (RC48-ADC, RC98-ADC)

Not yet recruiting
  • Gastric Cancer
  • Beijing, Beijing, China
    Remegen
Aug 21, 2022

Stomach Tumors, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Tiragolumab, Oxaliplatin)

Active, not recruiting
  • Stomach Neoplasms
  • +2 more
  • Beijing, China
  • +10 more
Dec 21, 2022

Gastric Cancer Trial in Seoul (Variltinib, Paclitaxel)

Active, not recruiting
  • Gastric Cancer
  • Variltinib, Paclitaxel
  • Seoul, Korea, Republic of
    Yonsei University Health System, Yonsei Cancer Center
May 27, 2022

Gastric Cancer Trial in Seoul (Apatinib mesylate)

Completed
  • Gastric Cancer
  • Apatinib mesylate
  • Seoul, Songpa-gu, Korea, Republic of
    Asan medical center
Jul 20, 2022

Metastatic Gastric Cancer Trial in Zhengzhou (fruquintinib+toripalimab + SOX)

Recruiting
  • Metastatic Gastric Cancer
  • fruquintinib+toripalimab + SOX
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Aug 17, 2022

Stomach Cancer Trial in Beijing (KN026/Placbo Injection, Paclitaxel Injection, Docetaxel Injection)

Recruiting
  • Stomach Cancer
  • KN026/Placbo Injection
  • +3 more
  • Beijing, China
    Chinese PLA General Hospital
Jun 16, 2022

Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) Trial in Wuwei, Shanghai (HLX07+HLX10+oxaliplatin+capecitabine,

Recruiting
  • Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
  • Wuwei, Gansu, China
  • +1 more
Apr 25, 2022

Gastric Cancer Trial in Seoul (pembrolizumab plus ramucirumab)

Recruiting
  • Gastric Cancer
  • pembrolizumab plus ramucirumab
  • Seoul, Korea, Republic of
  • +1 more
Feb 23, 2022

Gastric Cancer Trial in Shanghai (HLX22, Placebo, Trastuzumab)

Recruiting
  • Gastric Cancer
  • Shanghai, China
    Shanghai East Hospital
Apr 24, 2022

Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer Trial in Milan (Embolization)

Recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • Embolization
  • Milan, Italy
    IRCCS Ospedale San Raffaele
Feb 3, 2023